GlassScriptPhysician profile
George W Vick, II
NPI 1730150293
$1,520.13
in general payments reported to CMS, 2019-2025
21 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $33.72 · 2021: $454 · 2022: $459 · 2023: $194 · 2024: $18.67 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $382.06 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $171.34 | 2022-2025 | |
| Therapeuticsmd, INC. | $152.92 | 2019-2022 | |
| Coopersurgical, INC. | $145.94 | 2020-2025 | Endosee, Mara Console |
| Aspira Women'S Health INC | $111.90 | 2021-2022 | |
| Astellas Pharma US INC | $80.46 | 2023-2025 | Veozah |
| Avion Pharmaceuticals | $68.58 | 2019-2022 | |
| Myovant Sciences INC. | $63.41 | 2021-2022 | |
| Exeltis, USA INC. | $62.61 | 2019-2023 | Slynd |
| Hologic Sales and Service, LLC | $53.18 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Daiichi Sankyo INC. | $42.96 | 2019-2022 | |
| Agile Therapeutics, INC. | $37.87 | 2021-2022 | |
| Evofem Biosciences, INC. | $26.03 | 2021 | |
| Organon LLC | $21.59 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $18.97 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.10 | 2023 | |
| Novo Nordisk INC | $15.61 | 2023 | Saxenda, Wegovy |
| Shield Therapeutics INC | $12.76 | 2023 | Accrufer |
| Mylan Pharmaceuticals INC. | $11.93 | 2019 | |
| Dysis Medical, INC. | $11.71 | 2021 | |
| Roche Diagnostics Corporation | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Vick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.